Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: January-31-10
Credit Expiration Date: January-31-11

Faculty

Gregory Diette, MD, MHS
Associate Professor
Director of Clinical Research
Division of Pulmonary and Critical Care Medicine
The Johns Hopkins University School of Medicine
Baltimore, MD


Howard Garber, MD, MPH
Medical Director
Johns Hopkins HealthCare LLC
Glen Burnie, MD

Credit Hours

Physicians CME: 1 credit
Pharmacists CPE: 1 contact hour (0.1 CEU)

Medium

Online Presentation

Program Description

THIS ACTIVITY WAS ORIGINALLY PRESENTED AS A LIVE AUDIOCONFERENCE SERIES BEGINNING NOVEMBER 4, 2009. IF YOU RECEIVED CREDIT FOR PARTICIPATING IN THE AUDIOCONFERENCE, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE ACTIVITY.

The updated National Asthma Education and Prevention Program (NAEPP) guidelines are designed to improve asthma care by providing clinicians with the most current scientific knowledge. As managed care professionals increasingly become aware of how to leverage the Third Expert Panel Report (EPR3) recommendations, asthma patients will benefit with better treatment outcomes. Managed care executives need further education to understand the rationale for the EPR3 recommendations, including the rationale for the new direction that separates asthma control from asthma severity. They need education on the current development in tools to measure asthma control in order to better understand the variable nature of asthma and develop appropriate therapeutic regimens. Continuing education on these important asthma topics will help ensure better care and improve outcomes in asthma patients.

Program Developer/Facilitator


.

Target Audience

Managed care medical directors, pharmacy directors, physicians, pharmacists and other managed care professionals.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Review how recent clinical data and the updated NAEPP guidelines should be leveraged to improve the performance of clinicians who are treating patients with asthma.
  2. Develop strategies for tailoring therapy based on different patient characteristics.
  3. Review various types of asthma management programs used by managed care organizations.
  4. Review how ongoing research may improve asthma management.

Disclosures

It is the policy of the accredited providers to ensure balance, independence, objectivity and scientific rigor in all of its continuing education programs. Faculty must disclose to program participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial products discussed in an educational presentation.

Dr. Diette discloses that he has received honoraria for serving as a consultant to GlaxoSmithKline, Merck, and Healthways; he has served on speakers bureaus for AstraZeneca, Boehringer-Ingelheim, Pfizer, and Schering-Plough; and he has received grant support from Eumedic and Hill-Rom.

Dr. Garber discloses that he has no current financial relationships with commercial interests and/or the opportunity to affect content relevant to the products or services of those commercial interests.

The staff of NAMCP, ProCE, and MCM have no real or potential conflicts of interests. Katie Eads, VP Education of NAMCP, has no real or perceived financial relationships to disclose. Joseph Kim, MD, VP of Medical Affairs of Medical Communications Media has no real or perceived conflicts of interest to disclose. Leslie Sharp, Editorial Director of Medical Communications Media has no real or perceived conflicts of interest to disclose.

Please note: The opinions expressed in this program should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental, and participants are advised to consult prescribing information and professional literature.

Credit Statements

Physicians: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the National Association of Managed Care Physicians (NAMCP) and Medical Communications Media, Inc. The NAMCP is accredited by the ACCME to provide continuing medical education to physicians.

NAMCP designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists: ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-10-012-H01-P has been assigned to this knowledge-based home-study web program (initial release date 01-31-10). This program is approved for 1.0 contact hours (0.10 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be available immediately online at www.cmecorner.com following completion of the web program. Participants must view the entire program, complete a program evaluation form, and complete a post-test with a score of 70% or higher to receive pharmacy CE credit. No partial credit will be given.

Commercial Support Statements

Supported through an educational grant
from Schering-Plough.

Certificate Fee

$0.00

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS